Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | ATXN2 | Q99700 | 1/20 | 0.39 |
| ▸ | TGM2 | P21980 | 2/20 | 0.38 |
| ▸ | SLC6A7 | Q99884 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8209132 | 0.84 | PLA2G2A (0.40) | SMN1; SMN2 | |
| SCHEMBL7683498 | 0.74 | KDM1A (0.49) | SIGMAR1PARP1GAATGM2 | |
| SCHEMBL7683566 | 0.70 | GAA (0.54) | SIGMAR1SMN1; SMN2GAA | |
| SCHEMBL4588381 | 0.69 | MEN1 (0.64) | SIGMAR1SMN1; SMN2GAA | |
| SCHEMBL3970461 | 0.69 | MEN1 (0.64) | SIGMAR1SMN1; SMN2GAA | |
| SCHEMBL5873672 | 0.69 | GAA (0.55) | SIGMAR1SMN1; SMN2GAA | |
| SCHEMBL28406248 | 0.69 | PARP1 (0.59) | SIGMAR1PARP1SMN1; SMN2GAA | |
| SCHEMBL31329561 | 0.68 | MEN1 (0.62) | SIGMAR1SMN1; SMN2GAA | |
| SCHEMBL3778880 | 0.68 | MEN1 (0.66) | SIGMAR1SMN1; SMN2 | |
| SCHEMBL17272 | 0.68 | MEN1 (0.66) | SIGMAR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6083479-A | Contrast media for infarction and necrosis imaging | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-07-04 | — | — | US | disclosed |